Literature DB >> 26727524

Nicotine Enhances the Hypnotic and Hypothermic Effects of Alcohol in the Mouse.

Cassandra A Slater1, Asti Jackson1, Pretal P Muldoon1, Anton Dawson1, Megan O'Brien1, Lindsey G Soll2, Rehab Abdullah1, F Ivy Carroll3, Andrew R Tapper2, Michael F Miles1, Matthew L Banks1, Jill C Bettinger1, Imad M Damaj1.   

Abstract

BACKGROUND: Ethanol (EtOH) and nicotine abuse are 2 leading causes of preventable mortality in the world, but little is known about the pharmacological mechanisms mediating co-abuse. Few studies have examined the interaction of the acute effects of EtOH and nicotine. Here, we examine the effects of nicotine administration on the duration of EtOH-induced loss of righting reflex (LORR) and characterize the nature of their pharmacological interactions in C57BL/6J mice.
METHODS: We assessed the effects of EtOH and nicotine and the nature of their interaction in the LORR test using isobolographic analysis after acute injection in C57BL/6J male mice. Next, we examined the importance of receptor efficacy using nicotinic partial agonists varenicline and sazetidine. We evaluated the involvement of major nicotinic acetylcholine receptor (nAChR) subtypes using nicotinic antagonist mecamylamine and nicotinic α4- and α7-knockout mice. The selectivity of nicotine's actions on EtOH-induced LORR was examined by testing nicotine's effects on the hypnotic properties of ketamine and pentobarbital. We also assessed the development of tolerance after repeated nicotine exposure. Last, we assessed whether the effects of nicotine on EtOH-induced LORR extend to hypothermia and EtOH intake in the drinking in the dark (DID) paradigm.
RESULTS: We found that acute nicotine injection enhances EtOH's hypnotic effects in a synergistic manner and that receptor efficacy plays an important role in this interaction. Furthermore, tolerance developed to the enhancement of EtOH's hypnotic effects by nicotine after repeated exposure of the drug. α4* and α7 nAChRs seem to play an important role in nicotine-EtOH interaction in the LORR test. In addition, the magnitude of EtOH-induced LORR enhancement by nicotine was more pronounced in C57BL/6J than DBA/2J mice. Furthermore, acute nicotine enhanced ketamine and pentobarbital hypnotic effects in the mouse. Finally, nicotine enhanced EtOH-induced hypothermia but decreased EtOH intake in the DID test.
CONCLUSIONS: Our results demonstrate that nicotine synergistically enhances EtOH-induced LORR in the mouse.
Copyright © 2016 by the Research Society on Alcoholism.

Entities:  

Keywords:  Ethanol; Loss of Righting Reflex; Mice; Nicotine

Mesh:

Substances:

Year:  2016        PMID: 26727524      PMCID: PMC4700556          DOI: 10.1111/acer.12918

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  49 in total

1.  Forward, relaxed, and reverse selection for reduced and enhanced sensitivity to ethanol's locomotor stimulant effects in mice.

Authors:  Tamara J Phillips; Elaine H Shen; Carrie S McKinnon; Sue Burkhart-Kasch; Christina N Lessov; Abraham A Palmer
Journal:  Alcohol Clin Exp Res       Date:  2002-05       Impact factor: 3.455

2.  Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice.

Authors:  Linzy M Hendrickson; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Psychopharmacology (Berl)       Date:  2009-02-27       Impact factor: 4.530

3.  The α6 nicotinic acetylcholine receptor subunit influences ethanol-induced sedation.

Authors:  Helen M Kamens; Nicole R Hoft; Ryan J Cox; Jill H Miyamoto; Marissa A Ehringer
Journal:  Alcohol       Date:  2012-05-07       Impact factor: 2.405

4.  Nicotinic acetylcholine receptors containing the α4 subunit modulate alcohol reward.

Authors:  Liwang Liu; Linzy M Hendrickson; Melissa J Guildford; Rubing Zhao-Shea; Paul D Gardner; Andrew R Tapper
Journal:  Biol Psychiatry       Date:  2012-11-09       Impact factor: 13.382

5.  Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.

Authors:  Mirko Moroni; Isabel Bermudez
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption.

Authors:  Linzy M Hendrickson; Paul Gardner; Andrew R Tapper
Journal:  Channels (Austin)       Date:  2011-03-01       Impact factor: 2.581

7.  Correlated responses to selection in FAST and SLOW mice: effects of ethanol on ataxia, temperature, sedation, and withdrawal.

Authors:  E H Shen; J D Dorow; M Huson; T J Phillips
Journal:  Alcohol Clin Exp Res       Date:  1996-06       Impact factor: 3.455

8.  Attenuation of ethanol-induced ataxia by alpha(4)beta(2) nicotinic acetylcholine receptor subtype in mouse cerebellum: a functional interaction.

Authors:  N Taslim; S Al-Rejaie; M Saeed Dar
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

9.  Genetic determinants of sensitivity to ethanol in inbred mice.

Authors:  J C Crabbe; E S Gallaher; T J Phillips; J K Belknap
Journal:  Behav Neurosci       Date:  1994-02       Impact factor: 1.912

Review 10.  Ethanol's molecular targets.

Authors:  R Adron Harris; James R Trudell; S John Mihic
Journal:  Sci Signal       Date:  2008-07-15       Impact factor: 8.192

View more
  2 in total

1.  Knockout of alpha 5 nicotinic acetylcholine receptors subunit alters ethanol-mediated behavioral effects and reward in mice.

Authors:  Anton Dawson; Jennifer T Wolstenholme; Monzurul A Roni; Vera C Campbell; Asti Jackson; Cassandra Slater; Deniz Bagdas; Erika E Perez; Jill C Bettinger; Mariella De Biasi; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2018-06-23       Impact factor: 5.250

2.  Promoting activity of (α4)3(β2)2 nicotinic cholinergic receptors reduces ethanol consumption.

Authors:  Jingyi Wang; Angelo Blasio; Holly L Chapman; Christelle Doebelin; Victor Liaw; Alexander Kuryatov; Simone M Giovanetti; Jon Lindstrom; Li Lin; Michael D Cameron; Theodore M Kamenecka; Matthew B Pomrenze; Robert O Messing
Journal:  Neuropsychopharmacology       Date:  2019-08-08       Impact factor: 7.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.